Therefore, we suggest that BSK may be an effective agent for treating obesity induced insulin resistance and that the active compounds in BSK could be further investigated for the detailed molecular mechanisms involved in adipogenesis regulation. Here, EPHA5 is linked to obesity due to melanocortin 4 receptor deficiency.